Apogee Therapeutics | SCHEDULE 13G: Others
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McKenna Mark C.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Jane
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apogee Therapeutics | 8-K: Current report